How to Help Your Patients Save Money on Sterile Water for Injection: A Provider's Guide to Savings Programs

For most patients, Sterile Water for Injection (SWFI) is a background supply item they barely think about—it arrives with their home infusion kit and they reconstitute their medication as instructed. But for providers and infusion pharmacists managing cost-sensitive patients during an active shortage, SWFI costs and access have become a real clinical and financial challenge.

This guide is written for prescribers, pharmacists, and infusion therapy coordinators. It covers the cost landscape for SWFI, how to ensure patients receive the best possible insurance coverage, and clinical strategies that can reduce SWFI consumption entirely.

Understanding How SWFI Is Billed

Sterile Water for Injection is not billed like a standalone prescription at a retail pharmacy. Understanding the billing mechanism helps providers advocate effectively for their patients:

Home Infusion Bundled Billing

In home infusion settings, SWFI is typically billed as part of the bundled per-diem or per-dose home infusion rate—not as a separate drug charge. Commercial insurers and Medicare Part B's home infusion benefit generally cover SWFI as a supply component of the infusion service. This means patients on a formal home infusion program should not be paying separately for SWFI in most cases.

If a patient reports being charged separately for SWFI, the infusion pharmacy's billing team should review whether the supply is being billed correctly under the home infusion benefit. Billing SWFI separately as a pharmacy claim can result in patient out-of-pocket charges that would otherwise be avoided under the bundled benefit.

Medicare Part B Home Infusion Benefit

Since January 1, 2021, Medicare Part B covers home infusion therapy services including nursing visits, patient training, and drug administration supplies (including diluents like SWFI) for approved drug categories. Qualifying conditions include anti-infective therapy, chemotherapy, pain management, and others. Under this benefit, SWFI and related supplies are covered as part of the per-diem infusion services payment—not separately.

For patients not covered under the Medicare home infusion benefit (e.g., those receiving subcutaneous injectable hormones or peptides at home without a formal infusion program), SWFI may need to be purchased out of pocket or through a DME benefit if applicable.

Cost Reduction Strategy 1: Switch to Bacteriostatic Water for Injection Where Clinically Appropriate

For patients injecting medications that permit Bacteriostatic Water for Injection (BWFI)—such as injectable growth hormone, testosterone, and many subcutaneous biologics—switching from single-dose SWFI vials to multi-dose 30 mL BWFI vials reduces both cost and supply consumption. A single 30 mL BWFI vial can serve multiple doses over 28 days, compared to a separate SWFI vial for each dose.

Critical clinical check: Confirm the specific drug and patient population allow BWFI. Contraindications include neonates (benzyl alcohol toxicity), intrathecal/epidural routes, and drugs with preservative-free labeling requirements.

Cost Reduction Strategy 2: Shift to Commercially Premixed Formulations

For patients on IV antibiotics, switching from lyophilized vials (requiring SWFI reconstitution) to commercially premixed IV bags eliminates the need for SWFI entirely. Premixed formulations are available for many first-line IV antibiotics including vancomycin, piperacillin-tazobactam, meropenem, and cefepime.

While premixed formulations may have a higher per-dose acquisition cost, they eliminate the SWFI supply dependency and reduce pharmacy preparation time. For cost-sensitive patients, the net total cost (drug + diluent + pharmacy prep) may be comparable or lower. Review payer formulary coverage for premixed alternatives at your patient's infusion pharmacy.

Cost Reduction Strategy 3: Optimize Infusion Provider Selection

Not all infusion providers bill at the same rates or have the same GPO contracts for purchasing SWFI. During shortage periods, some infusion providers have better supply access than others due to their wholesale relationships. When referring a patient to home infusion, consider whether the provider has confirmed SWFI supply and competitive pricing, particularly if the patient is cost-sensitive.

Cost Reduction Strategy 4: Institutional Conservation (Reduce Per-Patient SWFI Use)

ASHP recommends several institutional conservation strategies that reduce SWFI consumption per patient:

Batch-compounding: Prepare multiple doses from a single SWFI vial or bag at once rather than opening a separate vial for each dose, reducing vial waste.

Use large-volume SWFI bags (1,000 mL or 2,000 mL) in a controlled sterile environment to batch-fill vials or syringes rather than using individual single-dose vials for each preparation.

Review formulary for medications with premixed alternatives to route orders away from SWFI-dependent reconstitution.

Are There Manufacturer Savings Programs for SWFI?

Unlike branded prescription drugs, Sterile Water for Injection has no manufacturer patient assistance programs (PAPs) or co-pay assistance cards. It is a commodity generic product sold at low unit cost through wholesale channels. Financial support for SWFI must be accessed through:

Insurance billing optimization (ensure it is covered under the home infusion bundled benefit, not billed as a separate retail prescription).

GPO contract pricing for institutions and infusion pharmacies.

Clinical alternatives (BWFI, premixed formulations) that reduce the volume of SWFI needed.

340B drug pricing programs for qualifying federally-qualified health centers and covered entities.

How medfinder Helps Providers and Patients Find SWFI

During shortage conditions, access is often more urgent than cost. medfinder helps providers and their patients locate pharmacies that have SWFI and injectable medications in stock—saving clinical staff and patients hours of phone calls. Visit medfinder.com/providers to learn more about how medfinder supports provider practices managing patients with hard-to-find medications.

For the patient-facing version of this savings guide, see: How to Save Money on Sterile Water for Injection in 2026.